Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
A clinical protocol was developed for the management of adult outpatients with
community-acquired pneumonia (CAP) and Pneumonia Severity Index risk classes I-II. Patients
are assigned to oral azithromycin or levofloxacin according to procalcitonin (PCT) levels
measured with a rapid point-of-care method. When PCT levels are <0.5 ng/ml, azithromycin, 500
mg/day is given orally for 5 days; if PCT is ≥0.5 ng/ml, levofloxacin, 500 mg/day is given
orally for 7 days
Phase:
Phase 4
Details
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana